Table 3 LGE result in study groups (after exclusion of non-contrast study)
Types and sub-types of cardiomyopathies | No enhancement (N = 16) | Enhancement (N = 15) |
|---|---|---|
Primary dilated | 5 (35.3) | 1 (6.6) |
Secondary dilated post myocarditis | – | 6 (40) |
Secondary dilated toxins, drugs | 1 (5.9) | – |
Hypertrophic | 10 (58.8) | 4 (26.6) |
Non-compaction | – | – |
ARVD | – | 1 (6.6) |
Restrictive | – | – |
Infiltrative thalassemia | – | – |
Infiltrative others | – | 1 (6.6) |
Ischemic | – | 2 (13.3) |
Test of significance | 19.4 | |
p value | 0.002* | |